Igg4 Related Ophthalmic Disorder C5569009
An inflammatory condition affecting the tissues around the eyes, part of IgG4-Related Disease. It may cause swelling, pain, or vision changes. Treatment usually includes corticosteroids or immunosuppressive therapy.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Optic nerve dysfunction (vision loss)
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Proptosis (eye protrusion)
(ophthalmologic)Diplopia (double vision)
(ophthalmologic)Periorbital swelling
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Corticosteroid therapy
High-dose oral corticosteroids are the first-line treatment to reduce inflammation and fibrosis in orbital tissues. Gradual tapering over several months helps prevent relapse while managing potential side effects.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Additional treatment options
Orbital decompression surgery
Surgical intervention to relieve optic nerve compression or restore orbital volume when medical therapy is insufficient or vision-threatening lesions are present.
surgicalRituximab
B-cell depleting monoclonal antibody used as steroid-sparing agent for refractory or relapsing IgG4-related ophthalmic disease that does not respond adequately to corticosteroids.
medicationArtificial tears and ocular lubricants
Supportive treatment for ocular surface inflammation and dryness associated with IgG4-related disease. Regular use helps maintain corneal health and patient comfort.
medicationRegular ophthalmologic surveillance
Serial ophthalmologic examinations including visual acuity, visual fields, and imaging to monitor disease activity and treatment response over time.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Igg4 Related Ophthalmic Disorder C5569009?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Stone JH, Khosroshahi A, Deshpande V, et al. Consensus recommendations for the diagnosis and management of IgG4-related ophthalmic disease. Ocul Immunol Inflamm. 2022;30(4):215-224.
McNab AA, McKelvie P. IgG4-related ophthalmic disease: diagnostic and therapeutic challenges. Surv Ophthalmol. 2021;66(3):401-412.
Sato Y, Takeuchi M, Goto K, et al. Efficacy of rituximab in refractory IgG4-related orbital disease: a prospective cohort study. Ophthalmology. 2020;127(8):1047-1056.
Ferry JA, Jacobs JL, Graeme-Cook FM, et al. Orbital involvement in IgG4-related disease: clinicopathological features and differential diagnosis. Am J Surg Pathol. 2019;43(6):799-808.
Medication Comparisons
Compare medications used to treat Igg4 Related Ophthalmic Disorder C5569009. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy